The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MS

被引:13
作者
Goey, Andrew K. L. [1 ]
Rosing, Hilde [2 ]
Meijerman, Irma [3 ]
Sparidans, Rolf W. [1 ]
Schellens, Jan H. M. [1 ,4 ]
Beijnen, Jos H. [1 ,2 ]
机构
[1] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, NL-3584 CG Utrecht, Netherlands
[2] Slotervaart Hosp, Netherlands Canc Inst, Dept Pharm & Pharmacol, NL-1066 EC Amsterdam, Netherlands
[3] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Div Pharmacol, NL-3584 CG Utrecht, Netherlands
[4] Netherlands Canc Inst, Dept Med Oncol, Div Clin Pharmacol, NL-1066 CX Amsterdam, Netherlands
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2012年 / 902卷
关键词
Dodeca-2E; 4E; 8Z; 10E/Z-tetraenoic acid isobutylamides; Echinacea purpurea; Alkylamide; LC-MS/MS; Human plasma; ALKAMIDES; PHARMACOKINETICS; BIOAVAILABILITY; ROOTS; ANGUSTIFOLIA; ALKYLAMIDES; SYSTEM;
D O I
10.1016/j.jchromb.2012.06.022
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Alkylamides are a group of active components of the widely used herb Echinacea purpurea (E. purpurea), which have immunostimulatory and anti-inflammatory effects. For the most abundant alkylamides, dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (DTAI), an LC-MS/MS assay has been developed and validated for quantification in human plasma. This assay will be used to support a clinical interaction study with E. purpurea. A 300 mu L plasma aliquot underwent liquid-liquid extraction with diethylether-n-hexane (50:50, v/v). After evaporization and reconstitution in 100 mu L of acetonitrile-water (50:50, v/v) 20 mu L. of sample were injected into the HPLC system. Chromatographic separation was achieved with a Polaris 3 C18-A column (50 mm x 2 mm ID, particle size 3 mu m), a flow rate of 0.3 mL/min and isocratic elution with acetonitrile-water (50:50, v/v) containing 0.1% formic acid during the first 5 min. Hereafter, gradient elution was applied for 0.5 min, followed by restoration of the initial isocratic conditions. The total run time was 7.5 min. The assay was validated over a concentration range from 0.01 to 50 ng/mL for DTAI, with a lower limit of quantification of 0.01 ng/mL Validation results show that DTAI can be accurately and precisely quantified in human plasma. DTAI also demonstrated to be chemically stable under relevant conditions. Finally, the applicability of this assay has been successfully demonstrated by measuring the plasma concentration of DTAI in patients after ingestion of a commercial extract of E. purpurea. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 156
页数:6
相关论文
共 13 条
[1]   Absolute/Relative Bioavailability and Metabolism of Dodeca-2E,4E,8Z,10E/Z-Tetraenoic Acid Isobutylamides (Tetraenes) after Intravenous and Oral Single Doses to Rats [J].
Ardjomand-Woelkart, Karin ;
Kollroser, Manfred ;
Magnes, Christoph ;
Sinner, Frank ;
Frye, Reginald F. ;
Derendorf, Hartmut ;
Bauer, Rudolf ;
Butterweck, Veronika .
PLANTA MEDICA, 2011, 77 (16) :1794-1799
[2]   High performance liquid chromatography/electrospray ionization mass spectrometry for simultaneous analysis of alkamides and caffeic acid derivatives from Echinacea purpurea extracts [J].
Cech, NB ;
Eleazer, MS ;
Shoffner, LT ;
Crosswhite, MR ;
Davis, AC ;
Mortenson, AM .
JOURNAL OF CHROMATOGRAPHY A, 2006, 1103 (02) :219-228
[3]   Macrophage activating effects of new alkamides from the roots of Echinacea species [J].
Chen, Y ;
Fu, T ;
Tao, T ;
Yang, JH ;
Chang, Y ;
Wang, MH ;
Kim, L ;
Qu, LP ;
Cassady, J ;
Scalzo, R ;
Wang, XP .
JOURNAL OF NATURAL PRODUCTS, 2005, 68 (05) :773-776
[4]   Echinacea alkylamides modulate TNF-α gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways [J].
Gertsch, J ;
Schoop, R ;
Kuenzle, U ;
Suter, A .
FEBS LETTERS, 2004, 577 (03) :563-569
[5]   A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma [J].
Goey, Andrew K. L. ;
Sparidans, Rolf W. ;
Meijerman, Irma ;
Rosing, Hilde ;
Schellens, Jan H. M. ;
Beijnen, Jos H. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (01) :41-48
[6]   Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion [J].
Matthias, A ;
Addison, RS ;
Penman, KG ;
Dickinson, RG ;
Bone, KM ;
Lehmann, RP .
LIFE SCIENCES, 2005, 77 (16) :2018-2029
[7]   Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model [J].
Matthias, A ;
Blanchfield, JT ;
Penman, KG ;
Toth, I ;
Lang, CS ;
De Voss, JJ ;
Lehmann, RP .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (01) :7-13
[8]   Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS [J].
Spelman, Kevin ;
Wetschler, Matthew H. ;
Cech, Nadja B. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (05) :1141-1149
[9]  
Woelkart K, 2006, INT J CLIN PHARM TH, V44, P401
[10]   The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots [J].
Woelkart, K ;
Xu, W ;
Pei, Y ;
Makriyannis, A ;
Picone, RP ;
Bauer, R .
PLANTA MEDICA, 2005, 71 (08) :701-705